Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+32.4%
5Y CAGR+381.1%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+32.4%/yr
vs +249.3%/yr prior
5Y CAGR
+381.1%/yr
Recent deceleration
Acceleration
-216.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2577.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$98.60M+579.7%
2023$14.51M-41.8%
2022$24.94M-41.3%
2021$42.47M+187.3%
2020$14.78M+38543.6%
2019$38254.00-98.7%
2018$2.85M+898.2%
2017$285167.00+75.0%
2016$162927.00-